{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T21:37:10Z","timestamp":1771623430917,"version":"3.50.1"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T00:00:00Z","timestamp":1620000000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["AAPS J"],"DOI":"10.1208\/s12248-021-00587-9","type":"journal-article","created":{"date-parts":[[2021,5,3]],"date-time":"2021-05-03T17:02:59Z","timestamp":1620061379000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Choroid Plexus and Drug Removal Mechanisms"],"prefix":"10.1208","volume":"23","author":[{"given":"Austin","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6641-9101","authenticated-orcid":false,"given":"Joanne","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,3]]},"reference":[{"issue":"8","key":"587_CR1","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrn3921","volume":"16","author":"MP Lun","year":"2015","unstructured":"Lun MP, Monuki ES, Lehtinen MK. Development and functions of the choroid plexus-cerebrospinal fluid system. Nat Rev Neurosci. 2015;16(8):445\u201357.","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"587_CR2","doi-asserted-by":"publisher","DOI":"10.1002\/bies.201900186","volume":"42","author":"RM Fame","year":"2020","unstructured":"Fame RM, Cort\u00e9s-Campos C, Sive HL. Brain ventricular system and cerebrospinal fluid development and function: light at the end of the tube: a primer with latest insights. Bioessays. 2020;42(3):e1900186.","journal-title":"Bioessays."},{"key":"587_CR3","volume-title":"Anatomy and physiology","author":"JG Betts","year":"2013","unstructured":"Betts JG, Young KA, Wise JA, Johnson E, Poe B, Kruse DH, et al. Circulation and the central nervous system. In: Anatomy and physiology. OpenStax: Houston; 2013."},{"key":"587_CR4","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.expneurol.2015.02.032","volume":"267","author":"R Spector","year":"2015","unstructured":"Spector R, Keep RF, Snodgrass SR, Smith QR, Johanson CE. A balanced view of choroid plexus structure and function: focus on adult humans. Exp Neurol. 2015;267:78\u201386.","journal-title":"Exp Neurol"},{"issue":"4","key":"587_CR5","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1152\/physiol.00011.2010","volume":"25","author":"HH Damkier","year":"2010","unstructured":"Damkier HH, Brown PD, Praetorius J. Epithelial pathways in choroid plexus electrolyte transport. Physiology. 2010;25(4):239\u201349.","journal-title":"Physiology."},{"key":"587_CR6","first-page":"1","volume":"124","author":"H Davson","year":"1954","unstructured":"Davson H, Purvis C. Cryoscopic apparatus suitable for studies on aqueous humour and cerebro-spinal fluid. J Physiol. 1954;124:1\u201347 12P.","journal-title":"J Physiol"},{"issue":"4","key":"587_CR7","doi-asserted-by":"publisher","first-page":"344","DOI":"10.3171\/jns.1965.22.4.0344","volume":"22","author":"K Welch","year":"1965","unstructured":"Welch K, Sadler K. Electrical potentials of choroid plexus of the rabbit. J Neurosurg. 1965;22(4):344\u201351.","journal-title":"J Neurosurg"},{"issue":"1","key":"587_CR8","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1007\/s00401-009-0627-8","volume":"119","author":"H Wolburg","year":"2010","unstructured":"Wolburg H, Paulus W. Choroid plexus: biology and pathology. Acta Neuropathol. 2010;119(1):75\u201388.","journal-title":"Acta Neuropathol"},{"issue":"2","key":"587_CR9","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/nn.4475","volume":"20","author":"M Prinz","year":"2017","unstructured":"Prinz M, Priller J. The role of peripheral immune cells in the CNS in steady state and disease. Nat Neurosci. 2017;20(2):136\u201344.","journal-title":"Nat Neurosci"},{"issue":"10","key":"587_CR10","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1038\/nn.2923","volume":"14","author":"M Prinz","year":"2011","unstructured":"Prinz M, Priller J, Sisodia SS, Ransohoff RM. Heterogeneity of CNS myeloid cells and their roles in neurodegeneration. Nat Neurosci. 2011;14(10):1227\u201335.","journal-title":"Nat Neurosci"},{"issue":"1","key":"587_CR11","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1002\/embj.201386609","volume":"33","author":"M Schwartz","year":"2014","unstructured":"Schwartz M, Baruch K. The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. EMBO J. 2014;33(1):7\u201322.","journal-title":"EMBO J"},{"key":"587_CR12","volume-title":"Physiology and pathophysiology of the cerebrospinal fluid","author":"H Davson","year":"1987","unstructured":"Davson H, Welch K, Segal MB. Physiology and pathophysiology of the cerebrospinal fluid. Edinburgh\u2013London: Churchill Livingstone; 1987."},{"key":"587_CR13","unstructured":"Davson H. Segal MB. Physiology of the CSF and blood-brain barriers. Boca Raton, FL: CRC press; 1996."},{"key":"587_CR14","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.expneurol.2015.07.027","volume":"273","author":"R Spector","year":"2015","unstructured":"Spector R, Robert Snodgrass S, Johanson CE. A balanced view of the cerebrospinal fluid composition and functions: focus on adult humans. Exp Neurol. 2015;273:57\u201368.","journal-title":"Exp Neurol"},{"issue":"3","key":"587_CR15","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1042\/bj0780606","volume":"78","author":"RMC Dawson","year":"1961","unstructured":"Dawson RMC, Freinkel N. The distribution of free mesoinositol in mammalian tissues, including some observations on the lactating rat. Biochem J. 1961;78(3):606\u201310.","journal-title":"Biochem J"},{"issue":"5","key":"587_CR16","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1152\/jn.1960.23.5.485","volume":"23","author":"J de Rougemont","year":"1960","unstructured":"de Rougemont J, Ames A, Nesbett FB, Hofmann HF. Fluid formed by choroid plexus: a technique for its collection and a comparison of its electrolyte composition with serum and cisternal fluids. J Neurophysiol. 1960;23(5):485\u201395.","journal-title":"J Neurophysiol"},{"key":"587_CR17","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-1-60761-938-3_4","volume-title":"The Blood-Brain and Other Neural Barriers","author":"CE Johanson","year":"2011","unstructured":"Johanson CE, Stopa EG, McMillan PN. The Blood-Cerebrospinal Fluid Barrier: Structure and Functional Significance. In: Nag S, editor. The Blood-Brain and Other Neural Barriers. New York: Springer; 2011. p. 101\u201331."},{"key":"587_CR18","volume-title":"The Cerebrospinal Fluid","author":"RM Herndon","year":"2012","unstructured":"Herndon RM, Brumback RA. The Cerebrospinal Fluid. Boston\/Dordrecht\/London: Kluwer Academic Publishers; 2012."},{"key":"587_CR19","first-page":"9","volume-title":"Proteins: A Biochemical Approach","author":"EJ Thompson","year":"1988","unstructured":"Thompson EJ, The CSF. Proteins: A Biochemical Approach. Amsterdam: Elsevier; 1988. p. 9\u201326."},{"issue":"6","key":"587_CR20","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.anorl.2011.03.002","volume":"128","author":"L Sakka","year":"2011","unstructured":"Sakka L, Coll G, Chazal J. Anatomy and physiology of cerebrospinal fluid. Eur Ann Otorhinolaryngol Head Neck Dis. 2011;128(6):309\u201316.","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"issue":"1","key":"587_CR21","doi-asserted-by":"publisher","first-page":"R20","DOI":"10.1152\/ajpregu.1992.262.1.R20","volume":"262","author":"C Nilsson","year":"1992","unstructured":"Nilsson C, Stahlberg F, Thomsen C, Henriksen O, Herning M, Owman C. Circadian variation in human cerebrospinal fluid production measured by magnetic resonance imaging. Am J Physiol Integr Comp Physiol. 1992;262(1):R20\u20134.","journal-title":"Am J Physiol Integr Comp Physiol"},{"issue":"6","key":"587_CR22","doi-asserted-by":"publisher","first-page":"2485","DOI":"10.1523\/JNEUROSCI.3246-14.2015","volume":"35","author":"S Dreha-Kulaczewski","year":"2015","unstructured":"Dreha-Kulaczewski S, Joseph AA, Merboldt K-D, Ludwig H-C, G\u00e4rtner J, Frahm J. Inspiration is the major regulator of human CSF flow. J Neurosci. 2015;35(6):2485\u201391.","journal-title":"J Neurosci"},{"issue":"1","key":"587_CR23","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s00381-011-1617-4","volume":"28","author":"GA Bateman","year":"2012","unstructured":"Bateman GA, Brown KM. The measurement of CSF flow through the aqueduct in normal and hydrocephalic children: from where does it come, to where does it go? Childs Nerv Syst. 2012;28(1):55\u201363.","journal-title":"Childs Nerv Syst"},{"issue":"4","key":"587_CR24","doi-asserted-by":"publisher","first-page":"430","DOI":"10.3171\/jns.1966.25.4.0430","volume":"25","author":"RC Rubin","year":"1966","unstructured":"Rubin RC, Henderson ES, Ommaya AK, Walker MD, Rall DP. The production of cerebrospinal fluid in man and its modification by acetazolamide. J Neurosurg. 1966;25(4):430\u20136.","journal-title":"J Neurosurg"},{"issue":"4","key":"587_CR25","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1093\/brain\/91.4.707","volume":"91","author":"RW Cutler","year":"1968","unstructured":"Cutler RW, Page L, Galicich J, Watters GV. Formation and absorption of cerebrospinal fluid in man. Brain. 1968;91(4):707\u201320.","journal-title":"Brain."},{"issue":"4","key":"587_CR26","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1093\/brain\/93.4.679","volume":"93","author":"AV Lorenzo","year":"1970","unstructured":"Lorenzo AV, Page LK, Watters GV. Relationship between cerebrospinal fluid formation, absorption and pressure in human hydrocephalus. Brain. 1970;93(4):679\u201392.","journal-title":"Brain."},{"issue":"1","key":"587_CR27","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1002\/1097-0029(20010101)52:1<31::AID-JEMT5>3.0.CO;2-T","volume":"52","author":"JE Preston","year":"2001","unstructured":"Preston JE. Ageing choroid plexus-cerebrospinal fluid system. Microsc Res Tech. 2001;52(1):31\u20137.","journal-title":"Microsc Res Tech"},{"issue":"3 Part 1","key":"587_CR28","doi-asserted-by":"publisher","first-page":"500 LP \u2013 500","DOI":"10.1212\/WNL.40.3_Part_1.500","volume":"40","author":"C May","year":"1990","unstructured":"May C, Kaye JA, Atack JR, Schapiro MB, Friedland RP, Rapoport SI. Cerebrospinal fluid production is reduced in healthy aging. Neurology. 1990;40(3 Part 1):500 LP \u2013 500.","journal-title":"Neurology"},{"issue":"3","key":"587_CR29","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.neulet.2010.04.015","volume":"476","author":"CPC Chen","year":"2010","unstructured":"Chen CPC, Chen RL, Preston JE. The influence of cerebrospinal fluid turnover on age-related changes in cerebrospinal fluid protein concentrations. Neurosci Lett. 2010;476(3):138\u201341.","journal-title":"Neurosci Lett"},{"issue":"1","key":"587_CR30","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/2045-8118-9-3","volume":"9","author":"C Chiu","year":"2012","unstructured":"Chiu C, Miller MC, Caralopoulos IN, Worden MS, Brinker T, Gordon ZN, et al. Temporal course of cerebrospinal fluid dynamics and amyloid accumulation in the aging rat brain from three to thirty months. Fluids Barriers CNS. 2012;9(1):3.","journal-title":"Fluids Barriers CNS"},{"issue":"10","key":"587_CR31","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1212\/WNL.57.10.1763","volume":"57","author":"GD Silverberg","year":"2001","unstructured":"Silverberg GD, Heit G, Huhn S, Jaffe RA, Chang SD. Bronte\u2013Stewart H, et al. The cerebrospinal fluid production rate is reduced in dementia of the Alzheimer\u2019s type. Neurology. 2001;57(10):1763\u20136.","journal-title":"Neurology"},{"issue":"9","key":"587_CR32","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.2967\/jnumed.116.187211","volume":"58","author":"MJ de Leon","year":"2017","unstructured":"de Leon MJ, Li Y, Okamura N, Tsui WH, Saint-Louis LA, Glodzik L, et al. Cerebrospinal fluid clearance in alzheimer disease measured with dynamic PET. J Nucl Med. 2017;58(9):1471\u20136.","journal-title":"J Nucl Med"},{"issue":"10","key":"587_CR33","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.2967\/jnumed.118.223834","volume":"60","author":"JJ Schubert","year":"2019","unstructured":"Schubert JJ, Veronese M, Marchitelli L, Bodini B, Tonietto M, Stankoff B, et al. Dynamic 11C-PiB PET shows cerebrospinal fluid flow alterations in Alzheimer disease and multiple sclerosis. J Nucl Med. 2019;60(10):1452\u201360.","journal-title":"J Nucl Med"},{"issue":"5","key":"587_CR34","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1002\/jmri.20427","volume":"22","author":"N Alperin","year":"2005","unstructured":"Alperin N, Lee SH, Sivaramakrishnan A, Hushek SG. Quantifying the effect of posture on intracranial physiology in humans by MRI flow studies. J Magn Reson Imaging. 2005;22(5):591\u20136.","journal-title":"J Magn Reson Imaging"},{"issue":"6465","key":"587_CR35","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1126\/science.aax5440","volume":"366","author":"NE Fultz","year":"2019","unstructured":"Fultz NE, Bonmassar G, Setsompop K, Stickgold RA, Rosen BR, Polimeni JR, et al. Coupled electrophysiological, hemodynamic, and cerebrospinal fluid oscillations in human sleep. Science (80- ). 2019;366(6465):628\u201331.","journal-title":"Science (80- )"},{"issue":"6465","key":"587_CR36","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1126\/science.aaz5191","volume":"366","author":"S Grubb","year":"2019","unstructured":"Grubb S, Lauritzen M. Deep sleep drives brain fluid oscillations. Science. 2019;366(6465):572\u20133.","journal-title":"Science."},{"issue":"4","key":"587_CR37","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.neuint.2003.11.006","volume":"45","author":"NJ Abbott","year":"2004","unstructured":"Abbott NJ. Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology. Neurochem Int. 2004;45(4):545\u201352.","journal-title":"Neurochem Int"},{"issue":"12","key":"587_CR38","doi-asserted-by":"publisher","first-page":"2583","DOI":"10.1007\/s11064-015-1581-6","volume":"40","author":"NA Jessen","year":"2015","unstructured":"Jessen NA, Munk ASF, Lundgaard I, Nedergaard M. The glymphatic system: a beginner\u2019s guide. Neurochem Res. 2015;40(12):2583\u201399.","journal-title":"Neurochem Res"},{"issue":"7","key":"587_CR39","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1517\/17425247.2016.1171315","volume":"13","author":"WM Pardridge","year":"2016","unstructured":"Pardridge WM. CSF, blood-brain barrier, and brain drug delivery. Expert Opin Drug Deliv. 2016;13(7):963\u201375.","journal-title":"Expert Opin Drug Deliv"},{"issue":"1","key":"587_CR40","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1113\/jphysiol.1970.sp009159","volume":"209","author":"H Davson","year":"1970","unstructured":"Davson H, Segal MB. The effects of some inhibitors and accelerators of sodium transport on the turnover of 22Na in the cerebrospinal fluid and the brain. J Physiol. 1970;209(1):131\u201353.","journal-title":"J Physiol"},{"issue":"2","key":"587_CR41","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1001\/archneur.1967.00470260086010","volume":"17","author":"WH Oldendorf","year":"1967","unstructured":"Oldendorf WH, Davson H. brain extracellular space and the sink action of cerebrospinal fluid: measurement of rabbit brain extracellular space using sucrose labeled with carbon 14. Arch Neurol. 1967;17(2):196\u2013205.","journal-title":"Arch Neurol"},{"issue":"3","key":"587_CR42","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00401-018-1812-4","volume":"135","author":"NJ Abbott","year":"2018","unstructured":"Abbott NJ, Pizzo ME, Preston JE, Janigro D, Thorne RG. The role of brain barriers in fluid movement in the CNS: is there a \u201cglymphatic\u201d system? Acta Neuropathol. 2018;135(3):387\u2013407.","journal-title":"Acta Neuropathol"},{"issue":"4","key":"587_CR43","doi-asserted-by":"publisher","first-page":"F319","DOI":"10.1152\/ajprenal.1981.240.4.F319","volume":"240","author":"HF Cserr","year":"1981","unstructured":"Cserr HF, Cooper DN, Suri PK, Patlak CS. Efflux of radiolabeled polyethylene glycols and albumin from rat brain. Am J Physiol Physiol. 1981;240(4):F319\u201328.","journal-title":"Am J Physiol Physiol"},{"key":"587_CR44","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/S0014-4835(77)80041-9","volume":"25","author":"HF Cserr","year":"1977","unstructured":"Cserr HF, Cooper DN, Milhorat TH. Flow of cerebral interstitial fluid as indicated by the removal of extracellular markers from rat caudate nucleus. Exp Eye Res. 1977;25:461\u201373.","journal-title":"Exp Eye Res"},{"issue":"1","key":"587_CR45","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1146\/annurev-pathol-051217-111018","volume":"13","author":"BA Plog","year":"2018","unstructured":"Plog BA, Nedergaard M. The glymphatic system in central nervous system health and disease: past, present, and future. Annu Rev Pathol Mech Dis. 2018;13(1):379\u201394.","journal-title":"Annu Rev Pathol Mech Dis"},{"issue":"46","key":"587_CR46","doi-asserted-by":"publisher","first-page":"18190","DOI":"10.1523\/JNEUROSCI.1592-13.2013","volume":"33","author":"M Wang","year":"2013","unstructured":"Wang M, Liao Y, Venkataraman A, Plog BA, Nedergaard M, Deane R, et al. Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain. J Neurosci. 2013;33(46):18190\u20139.","journal-title":"J Neurosci"},{"issue":"6156","key":"587_CR47","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1126\/science.1241224","volume":"342","author":"L Xie","year":"2013","unstructured":"Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, et al. Sleep drives metabolite clearance from the adult brain. Science (80- ). 2013;342(6156):373\u20137.","journal-title":"Science (80- )"},{"key":"587_CR48","doi-asserted-by":"publisher","first-page":"e27679","DOI":"10.7554\/eLife.27679","volume":"6","author":"AJ Smith","year":"2017","unstructured":"Smith AJ, Yao X, Dix JA, Jin B-J, Verkman AS. Test of the \u201cglymphatic\u201d hypothesis demonstrates diffusive and aquaporin-4-independent solute transport in rodent brain parenchyma. Huguenard J, editor. Elife. 2017;6:e27679.","journal-title":"Elife"},{"key":"587_CR49","doi-asserted-by":"publisher","first-page":"e40070","DOI":"10.7554\/eLife.40070","volume":"7","author":"H Mestre","year":"2018","unstructured":"Mestre H, Hablitz LM, Xavier ALR, Feng W, Zou W, Pu T, et al. Aquaporin-4-dependent glymphatic solute transport in the rodent brain. Kleinfeld D, Morrison SJ, editors. Elife. 2018;7:e40070.","journal-title":"Elife"},{"issue":"5","key":"587_CR50","doi-asserted-by":"publisher","first-page":"1492","DOI":"10.1021\/mp300495e","volume":"10","author":"DJ Wolak","year":"2013","unstructured":"Wolak DJ, Thorne RG. Diffusion of macromolecules in the brain: implications for drug delivery. Mol Pharm. 2013;10(5):1492\u2013504.","journal-title":"Mol Pharm"},{"issue":"37","key":"587_CR51","doi-asserted-by":"publisher","first-page":"9894","DOI":"10.1073\/pnas.1706942114","volume":"114","author":"KE Holter","year":"2017","unstructured":"Holter KE, Kehlet B, Devor A, Sejnowski TJ, Dale AM, Omholt SW, et al. Interstitial solute transport in 3D reconstructed neuropil occurs by diffusion rather than bulk flow. Proc Natl Acad Sci. 2017;114(37):9894\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"3","key":"587_CR52","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrd3028","volume":"9","author":"KM Giacomini","year":"2010","unstructured":"Giacomini KM, Huang S-M, Tweedie DJ, Benet LZ, Brouwer KLR, Chu X, et al. Membrane transporters in drug development. Nat Rev Drug Discov. 2010;9(3):215\u201336.","journal-title":"Nat Rev Drug Discov"},{"key":"587_CR53","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.phrs.2016.06.002","volume":"111","author":"DJ Wagner","year":"2016","unstructured":"Wagner DJ, Hu T, Wang J. Polyspecific organic cation transporters and their impact on drug intracellular levels and pharmacodynamics. Pharmacol Res. 2016;111:237\u201346.","journal-title":"Pharmacol Res"},{"issue":"3","key":"587_CR54","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1038\/nrd3028","volume":"9","author":"KM Giacomini","year":"2010","unstructured":"Giacomini KM, Huang S-M, Tweedie DJ, Benet LZ, Brouwer KLR, Chu X, et al. Membrane transporters in drug development. Nat Rev Drug Discov. 2010;9(3):215\u201336.","journal-title":"Nat Rev Drug Discov"},{"issue":"8","key":"587_CR55","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1038\/nrd4626","volume":"14","author":"L Lin","year":"2015","unstructured":"Lin L, Yee SW, Kim RB, Giacomini KM. SLC transporters as therapeutic targets: emerging opportunities. Nat Rev Drug Discov. 2015;14(8):543\u201360.","journal-title":"Nat Rev Drug Discov"},{"issue":"2","key":"587_CR56","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1124\/jpet.108.149831","volume":"329","author":"A Dahlin","year":"2009","unstructured":"Dahlin A, Royall J, Hohmann JG, Wang J. Expression profiling of the solute carrier gene family in the mouse brain. J Pharmacol Exp Ther. 2009;329(2):558\u201370.","journal-title":"J Pharmacol Exp Ther"},{"key":"587_CR57","doi-asserted-by":"publisher","first-page":"154","DOI":"10.3389\/fphar.2012.00154","volume":"3","author":"HTB Ho","year":"2012","unstructured":"Ho HTB, Dahlin A, Wang J. Expression Profiling of Solute Carrier Gene Families at the Blood-CSF Barrier. Front Pharmacol. 2012;3:154.","journal-title":"Front Pharmacol"},{"issue":"11","key":"587_CR58","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1124\/dmd.31.11.1337","volume":"31","author":"S Choudhuri","year":"2003","unstructured":"Choudhuri S, Cherrington NJ, Li N, Klaassen CD. Constitutive expression of various xenobiotic and endobiotic transporter mRNAs in the choroid plexus of rats. Drug Metab Dispos. 2003;31(11):1337\u201345.","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"587_CR59","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1111\/jnc.13147","volume":"134","author":"Y Uchida","year":"2015","unstructured":"Uchida Y, Zhang Z, Tachikawa M, Terasaki T. Quantitative targeted absolute proteomics of rat blood-cerebrospinal fluid barrier transporters: comparison with a human specimen. J Neurochem. 2015;134(6):1104\u201315.","journal-title":"J Neurochem"},{"issue":"10","key":"587_CR60","doi-asserted-by":"publisher","first-page":"3436","DOI":"10.1021\/acs.molpharmaceut.7b00449","volume":"14","author":"C Braun","year":"2017","unstructured":"Braun C, Sakamoto A, Fuchs H, Ishiguro N, Suzuki S, Cui Y, et al. Quantification of transporter and receptor proteins in dog brain capillaries and choroid plexus: relevance for the distribution in brain and CSF of selected BCRP and P-gp substrates. Mol Pharm. 2017;14(10):3436\u201347.","journal-title":"Mol Pharm"},{"issue":"2","key":"587_CR61","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1124\/dmd.119.089516","volume":"48","author":"Y Uchida","year":"2020","unstructured":"Uchida Y, Goto R, Takeuchi H, \u0141uczak M, Usui T, Tachikawa M, et al. Abundant expression of OCT2, MATE1, OAT1, OAT3, PEPT2, BCRP, MDR1, and xCT transporters in blood-arachnoid barrier of pig and polarized localizations at CSF- and blood-facing plasma membranes. Drug Metab Dispos. 2020;48(2):135\u201345.","journal-title":"Drug Metab Dispos"},{"key":"587_CR62","doi-asserted-by":"crossref","unstructured":"Akanuma S, Kubo Y, Hosoya K. Techniques for Evaluating Efflux Transport of Radiolabeled Drugs and Compounds from the Cerebrospinal Fluid Across the Blood-Cerebrospinal Fluid Barrier. In: Barichello T, editor. Blood-Brain Barrier. New York, NY: Springer New York; 2019. p. 231\u201348.\u00a0","DOI":"10.1007\/978-1-4939-8946-1_14"},{"issue":"1","key":"587_CR63","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/1743-8454-7-11","volume":"7","author":"J Kl\u00e4s","year":"2010","unstructured":"Kl\u00e4s J, Wolburg H, Terasaki T, Fricker G, Reichel V. Characterization of immortalized choroid plexus epithelial cell lines for studies of transport processes across the blood-cerebrospinal fluid barrier. Cerebrospinal Fluid Res. 2010;7(1):11.","journal-title":"Cerebrospinal Fluid Res."},{"issue":"6500","key":"587_CR64","doi-asserted-by":"publisher","first-page":"eaaz5626","DOI":"10.1126\/science.aaz5626","volume":"369","author":"L Pellegrini","year":"2020","unstructured":"Pellegrini L, Bonfio C, Chadwick J, Begum F, Skehel M, Lancaster MA. Human CNS barrier-forming organoids with cerebrospinal fluid production. Science (80- ). 2020;369(6500):eaaz5626.","journal-title":"Science (80- )"},{"issue":"7","key":"587_CR65","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1073\/pnas.96.7.3900","volume":"96","author":"VV Rao","year":"1999","unstructured":"Rao VV, Dahlheimer JL, Bardgett ME, Snyder AZ, Finch RA, Sartorelli AC, et al. Choroid plexus epithelial expression of MDR1 P glycoprotein and multidrug resistance-associated protein contribute to the blood\u2013cerebrospinal-fluid drug-permeability barrier. Proc Natl Acad Sci. 1999;96(7):3900\u20135.","journal-title":"Proc Natl Acad Sci"},{"issue":"10","key":"587_CR66","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1177\/002215549904701005","volume":"47","author":"B Gao","year":"1999","unstructured":"Gao B, Stieger B, No\u00e9 B, Fritschy J-M, Meier PJ. Localization of the organic anion transporting polypeptide 2 (Oatp2) in capillary endothelium and choroid plexus epithelium of rat brain. J Histochem Cytochem. 1999;47(10):1255\u201363.","journal-title":"J Histochem Cytochem"},{"issue":"5","key":"587_CR67","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1002\/cne.21808","volume":"510","author":"S Gazzin","year":"2008","unstructured":"Gazzin S, Strazielle N, Schmitt C, Fevre-Montange M, Ostrow JD, Tiribelli C, et al. Differential expression of the multidrug resistance-related proteins ABCb1 and ABCc1 between blood-brain interfaces. J Comp Neurol. 2008;510(5):497\u2013507.","journal-title":"J Comp Neurol"},{"issue":"5","key":"587_CR68","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1208\/s12248-017-0110-8","volume":"19","author":"ME Morris","year":"2017","unstructured":"Morris ME, Rodriguez-Cruz V, Felmlee MA. SLC and ABC Transporters: Expression, Localization, and Species Differences at the Blood-Brain and the Blood-Cerebrospinal Fluid Barriers. AAPS J. 2017;19(5):1317\u201331.","journal-title":"AAPS J."},{"issue":"2","key":"587_CR69","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1124\/pr.119.018762","volume":"72","author":"MA Felmlee","year":"2020","unstructured":"Felmlee MA, Jones RS, Rodriguez-Cruz V, Follman KE, Morris ME. Monocarboxylate transporters (SLC16): function, regulation, and role in health and disease. Daws LC, editor. Pharmacol Rev. 2020;72(2):466\u201385.","journal-title":"Pharmacol Rev"},{"issue":"3","key":"587_CR70","first-page":"1278","volume":"274","author":"JB Pritchard","year":"1995","unstructured":"Pritchard JB. Intracellular alpha-ketoglutarate controls the efficacy of renal organic anion transport. J Pharmacol Exp Ther. 1995;274(3):1278\u201384.","journal-title":"J Pharmacol Exp Ther"},{"issue":"1","key":"587_CR71","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1152\/physrev.00025.2013","volume":"95","author":"SK Nigam","year":"2015","unstructured":"Nigam SK, Bush KT, Martovetsky G, Ahn S-Y, Liu HC, Richard E, et al. The organic anion transporter (OAT) family: a systems biology perspective. Physiol Rev. 2015;95(1):83\u2013123.","journal-title":"Physiol Rev"},{"issue":"5","key":"587_CR72","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1124\/mol.61.5.982","volume":"61","author":"Y Nagata","year":"2002","unstructured":"Nagata Y, Kusuhara H, Endou H, Sugiyama Y. Expression and functional characterization of rat organic anion transporter 3 (rOat3) in the choroid plexus. Mol Pharmacol. 2002;61(5):982\u20138.","journal-title":"Mol Pharmacol"},{"issue":"5","key":"587_CR73","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1124\/mol.59.5.1277","volume":"59","author":"SH Cha","year":"2001","unstructured":"Cha SH, Sekine T, Fukushima J, Kanai Y, Kobayashi Y, Goya T, et al. Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol. 2001;59(5):1277\u201386.","journal-title":"Mol Pharmacol"},{"issue":"3","key":"587_CR74","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1124\/jpet.107.123323","volume":"322","author":"S Matsumoto","year":"2007","unstructured":"Matsumoto S, Yoshida K, Ishiguro N, Maeda T, Tamai I. Involvement of rat and human organic anion transporter 3 in the renal tubular secretion of topotecan [(S)-9-dimethylaminomethyl-10-hydroxy-camptothecin hydrochloride]. J Pharmacol Exp Ther. 2007;322(3):1246\u201352.","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"587_CR75","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1124\/jpet.300.3.918","volume":"300","author":"M Takeda","year":"2002","unstructured":"Takeda M, Khamdang S, Narikawa S, Kimura H, Kobayashi Y, Yamamoto T, et al. Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther. 2002;300(3):918\u201324.","journal-title":"J Pharmacol Exp Ther"},{"issue":"4","key":"587_CR76","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/s11095-005-2503-0","volume":"22","author":"H Tahara","year":"2005","unstructured":"Tahara H, Shono M, Kusuhara H, Kinoshita H, Fuse E, Takadate A, et al. Molecular cloning and functional analyses of OAT1 and OAT3 from cynomolgus monkey kidney. Pharm Res. 2005;22(4):647\u201360.","journal-title":"Pharm Res"},{"issue":"7","key":"587_CR77","doi-asserted-by":"publisher","first-page":"1104","DOI":"10.1016\/j.bcp.2005.06.024","volume":"70","author":"H Ueo","year":"2005","unstructured":"Ueo H, Motohashi H, Katsura T, Inui K. Human organic anion transporter hOAT3 is a potent transporter of cephalosporin antibiotics, in comparison with hOAT1. Biochem Pharmacol. 2005;70(7):1104\u201313.","journal-title":"Biochem Pharmacol"},{"issue":"4","key":"587_CR78","doi-asserted-by":"publisher","first-page":"F805","DOI":"10.1152\/ajprenal.00141.2019","volume":"317","author":"J Yin","year":"2019","unstructured":"Yin J, Wagner DJ, Prasad B, Isoherranen N, Thummel KE, Wang J. Renal secretion of hydrochlorothiazide involves organic anion transporter 1\/3, organic cation transporter 2, and multidrug and toxin extrusion protein 2-K. Am J Physiol Physiol. 2019;317(4):F805\u201314.","journal-title":"Am J Physiol Physiol"},{"issue":"9","key":"587_CR79","doi-asserted-by":"publisher","first-page":"3220","DOI":"10.1002\/jps.24489","volume":"104","author":"T Ebner","year":"2015","unstructured":"Ebner T, Ishiguro N, Taub ME. The use of transporter probe drug cocktails for the assessment of transporter-based drug-drug interactions in a clinical setting - proposal of a four component transporter cocktail. J Pharm Sci. 2015;104(9):3220\u20138.","journal-title":"J Pharm Sci"},{"issue":"5","key":"587_CR80","doi-asserted-by":"publisher","first-page":"3535","DOI":"10.1074\/jbc.M112.436972","volume":"288","author":"H Duan","year":"2013","unstructured":"Duan H, Wang J. Impaired monoamine and organic cation uptake in choroid plexus in mice with targeted disruption of the plasma membrane monoamine transporter (Slc29a4) gene. J Biol Chem. 2013;288(5):3535\u201344.","journal-title":"J Biol Chem"},{"issue":"10","key":"587_CR81","doi-asserted-by":"publisher","first-page":"1956","DOI":"10.1124\/dmd.107.015495","volume":"35","author":"M Zhou","year":"2007","unstructured":"Zhou M, Xia L, Wang J. Metformin transport by a newly cloned proton-stimulated organic cation transporter (plasma membrane monoamine transporter) expressed in human intestine. Drug Metab Dispos. 2007;35(10):1956\u201362.","journal-title":"Drug Metab Dispos"},{"issue":"9","key":"587_CR82","doi-asserted-by":"publisher","first-page":"2592","DOI":"10.1016\/j.xphs.2017.01.009","volume":"106","author":"Y Mimura","year":"2017","unstructured":"Mimura Y, Yasujima T, Ohta K, Inoue K, Yuasa H. Functional identification of plasma membrane monoamine transporter (PMAT\/SLC29A4) as an atenolol transporter sensitive to flavonoids contained in apple juice. J Pharm Sci. 2017;106(9):2592\u20138.","journal-title":"J Pharm Sci"},{"issue":"3","key":"587_CR83","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1124\/jpet.301.3.820","volume":"301","author":"C Shu","year":"2002","unstructured":"Shu C, Shen H, Teuscher NS, Lorenzi PJ, Keep RF, Smith DE. Role of PEPT2 in peptide\/mimetic trafficking at the blood-cerebrospinal fluid barrier: studies in rat choroid plexus epithelial cells in primary culture. J Pharmacol Exp Ther. 2002;301(3):820\u20139.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"587_CR84","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1124\/dmd.116.073320","volume":"45","author":"F Song","year":"2017","unstructured":"Song F, Hu Y, Jiang H, Smith DE. Species differences in human and rodent PEPT2-mediated transport of glycylsarcosine and cefadroxil in pichia pastoris transformants. Drug Metab Dispos. 2017;45(2):130\u20136.","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"587_CR85","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1124\/dmd.105.006791","volume":"34","author":"M Li","year":"2006","unstructured":"Li M, Anderson GD, Phillips BR, Kong W, Shen DD, Wang J. Interactions of amoxicillin and cefaclor with human renal organic anion and peptide transporters. Drug Metab Dispos. 2006;34(4):547\u201355.","journal-title":"Drug Metab Dispos"},{"issue":"19","key":"587_CR86","doi-asserted-by":"publisher","first-page":"8822","DOI":"10.1073\/pnas.91.19.8822","volume":"91","author":"GJ Zaman","year":"1994","unstructured":"Zaman GJ, Flens MJ, van Leusden MR, de Haas M, M\u00fclder HS, Lankelma J, et al. The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc Natl Acad Sci. 1994;91(19):8822\u20136.","journal-title":"Proc Natl Acad Sci"},{"issue":"19","key":"587_CR87","first-page":"7225","volume":"61","author":"H Zeng","year":"2001","unstructured":"Zeng H, Chen Z-S, Belinsky MG, Rea PA, Kruh GD. Transport of methotrexate (MTX) and folates by multidrug resistance protein (MRP) 3 and MRP1. Cancer Res. 2001;61(19):7225\u201332.","journal-title":"Cancer Res"},{"issue":"2","key":"587_CR88","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1161\/CIRCRESAHA.109.203596","volume":"106","author":"MJ Knauer","year":"2010","unstructured":"Knauer MJ, Urquhart BL, Meyer zu Schwabedissen HE, Schwarz UI, Lemke CJ, Leake BF, et al. Human skeletal muscle drug transporters determine local exposure and toxicity of statins. Circ Res. 2010;106(2):297\u2013306.","journal-title":"Circ Res"},{"issue":"4","key":"587_CR89","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1097\/00002030-200103090-00007","volume":"15","author":"IC van der Sandt","year":"2001","unstructured":"van der Sandt IC, Vos CM, Nabulsi L, Blom-Roosemalen MC, Voorwinden HH, de Boer AG, et al. Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood-brain barrier. AIDS. 2001;15(4):483\u201391.","journal-title":"AIDS."},{"issue":"3","key":"587_CR90","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1124\/dmd.111.041731","volume":"40","author":"DR de Waart","year":"2012","unstructured":"de Waart DR, van de Wetering K, Kunne C, Duijst S, Paulusma CC, Oude Elferink RPJ. Oral availability of cefadroxil depends on ABCC3 and ABCC4. Drug Metab Dispos. 2012;40(3):515\u201321.","journal-title":"Drug Metab Dispos"},{"issue":"17","key":"587_CR91","doi-asserted-by":"publisher","first-page":"7612","DOI":"10.1128\/MCB.24.17.7612-7621.2004","volume":"24","author":"M Leggas","year":"2004","unstructured":"Leggas M, Adachi M, Scheffer GL, Sun D, Wielinga P, Du G, et al. Mrp4 confers resistance to topotecan and protects the brain from chemotherapy. Mol Cell Biol. 2004;24(17):7612\u201321.","journal-title":"Mol Cell Biol"},{"key":"587_CR92","unstructured":"Chen Z-S, Lee K, Walther S, Raftogianis RB, Kuwano M, Zeng H, et al. Analysis of methotrexate and folate transport by multidrug resistance protein 4 (ABCC4): MRP4 is a component of the methotrexate efflux system. Cancer Res. 62(11):3144\u201350."},{"issue":"1","key":"587_CR93","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2174\/138920006774832550","volume":"7","author":"Q Tian","year":"2006","unstructured":"Tian Q, Zhang J, Chan SY. Chin Tan, Theresa M., Duan W, et al. Topotecan is a substrate for multidrug resistance associated protein 4. Curr Drug Metab. 2006;7(1):105\u201318.","journal-title":"Curr Drug Metab"},{"issue":"36","key":"587_CR94","doi-asserted-by":"publisher","first-page":"33747","DOI":"10.1074\/jbc.M104833200","volume":"276","author":"ZS Chen","year":"2001","unstructured":"Chen ZS, Lee K, Kruh GD. Transport of cyclic nucleotides and estradiol 17-beta-D-glucuronide by multidrug resistance protein 4. Resistance to 6-mercaptopurine and 6-thioguanine. J Biol Chem. 2001;276(36):33747\u201354.","journal-title":"J Biol Chem"},{"issue":"2","key":"587_CR95","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1124\/mol.106.028233","volume":"71","author":"T Imaoka","year":"2007","unstructured":"Imaoka T, Kusuhara H, Adachi M, Schuetz JD, Takeuchi K, Sugiyama Y. Functional involvement of multidrug resistance-associated protein 4 (MRP4\/ABCC4) in the renal elimination of the antiviral drugs adefovir and tenofovir. Mol Pharmacol. 2007;71(2):619\u201327.","journal-title":"Mol Pharmacol"},{"issue":"6","key":"587_CR96","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1124\/mol.106.031823","volume":"71","author":"L Ci","year":"2007","unstructured":"Ci L, Kusuhara H, Adachi M, Schuetz JD, Takeuchi K, Sugiyama Y. Involvement of MRP4 (ABCC4) in the luminal efflux of ceftizoxime and cefazolin in the kidney. Mol Pharmacol. 2007;71(6):1591\u20137.","journal-title":"Mol Pharmacol"},{"issue":"1","key":"587_CR97","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1681\/ASN.2005090966","volume":"18","author":"Maki Hasegawa","year":"2007","unstructured":"Hasegawa Maki, Kusuhara Hiroyuki, Adachi Masashi, Schuetz John D, Takeuchi Kenji, Sugiyama Yuichi. Multidrug resistance-associated protein 4 is involved in the urinary excretion of hydrochlorothiazide and furosemide. J Am Soc Nephrol. 2007;18(1):37\u201345.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"587_CR98","doi-asserted-by":"publisher","first-page":"F1332","DOI":"10.1152\/ajprenal.00319.2007","volume":"293","author":"AL VanWert","year":"2007","unstructured":"VanWert AL, Bailey RM, Sweet DH. Organic anion transporter 3 (Oat3\/Slc22a8) knockout mice exhibit altered clearance and distribution of penicillin G. Am J Physiol Physiol. 2007;293(4):F1332\u201341.","journal-title":"Am J Physiol Physiol"},{"issue":"2","key":"587_CR99","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s11095-007-9407-0","volume":"25","author":"AL VanWert","year":"2008","unstructured":"VanWert AL, Sweet DH. Impaired Clearance of methotrexate in organic anion transporter 3 (Slc22a8) knockout mice: a gender specific impact of reduced folates. Pharm Res. 2008;25(2):453\u201362.","journal-title":"Pharm Res"},{"issue":"1","key":"587_CR100","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/ajplegacy.1961.200.1.1","volume":"200","author":"JR Pappenheimer","year":"1961","unstructured":"Pappenheimer JR, Heisey SR, Jordan EF. Active transport of diodrast and phenolsulfonphthalein from cerebrospinal fluid to blood. Am J Physiol Content. 1961;200(1):1\u201310.","journal-title":"Am J Physiol Content"},{"issue":"2","key":"587_CR101","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1001\/archneur.1966.00470140003001","volume":"15","author":"RA Fishman","year":"1966","unstructured":"Fishman RA. Blood-brain and CSF barriers to penicillin and related organic acids. Arch Neurol. 1966;15(2):113\u201324.","journal-title":"Arch Neurol"},{"issue":"48","key":"587_CR102","doi-asserted-by":"publisher","first-page":"30088","DOI":"10.1074\/jbc.272.48.30088","volume":"272","author":"DH Sweet","year":"1997","unstructured":"Sweet DH, Wolff NA, Pritchard JB. Expression cloning and characterization of ROAT1: the basolateral organic anion transporter in rat kidney. J Biol Chem. 1997;272(48):30088\u201395.","journal-title":"J Biol Chem"},{"issue":"30","key":"587_CR103","doi-asserted-by":"publisher","first-page":"18526","DOI":"10.1074\/jbc.272.30.18526","volume":"272","author":"T Sekine","year":"1997","unstructured":"Sekine T, Watanabe N, Hosoyamada M, Kanai Y, Endou H. Expression cloning and characterization of a novel multispecific organic anion transporter. J Biol Chem. 1997;272(30):18526\u20139.","journal-title":"J Biol Chem"},{"issue":"7","key":"587_CR104","first-page":"2184","volume":"40","author":"U Bode","year":"1980","unstructured":"Bode U, Magrath IT, Bleyer WA, Poplack DG, Glaubiger DL. Active Transport of Methotrexate from Cerebrospinal Fluid in Humans. Cancer Res. 1980;40(7):2184\u20137.","journal-title":"Cancer Res."},{"issue":"30","key":"587_CR105","doi-asserted-by":"publisher","first-page":"26934","DOI":"10.1074\/jbc.M203803200","volume":"277","author":"DH Sweet","year":"2002","unstructured":"Sweet DH, Miller DS, Pritchard JB, Fujiwara Y, Beier DR, Nigam SK. Impaired Organic Anion Transport in Kidney and Choroid Plexus of Organic Anion Transporter 3 (Oat3 (Slc22a8)) Knockout Mice. J Biol Chem. 2002;277(30):26934\u201343.","journal-title":"J Biol Chem."},{"issue":"5","key":"587_CR106","doi-asserted-by":"publisher","first-page":"F972","DOI":"10.1152\/ajprenal.00356.2003","volume":"286","author":"D Sykes","year":"2004","unstructured":"Sykes D, Sweet DH, Lowes S, Nigam SK, Pritchard JB, Miller DS, et al. Organic anion transport in choroid plexus from wild-type and organic anion transporter 3 (Slc22a8)-null mice. Am J Physiol Ren Physiol. 2004;286(5):F972\u20138.","journal-title":"Am J Physiol Ren Physiol"},{"issue":"2","key":"587_CR107","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/0005-2736(95)80036-F","volume":"1235","author":"W Liu","year":"1995","unstructured":"Liu W, Liang R, Ramamoorthy S, Fei Y-J, Ganapathy ME, Hediger MA, et al. Molecular cloning of PEPT 2, a new member of the H+\/peptide cotransporter family, from human kidney. Biochim Biophys Acta Biomembr. 1995;1235(2):461\u20136.","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"4","key":"587_CR108","doi-asserted-by":"publisher","first-page":"236","DOI":"10.2133\/dmpk.23.236","volume":"23","author":"MA Kamal","year":"2008","unstructured":"Kamal MA, Keep RF, Smith DE. Role and relevance of PEPT2 in drug disposition, dynamics, and toxicity. Drug Metab Pharmacokinet. 2008;23(4):236\u201342.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"2","key":"587_CR109","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1016\/j.mam.2012.11.003","volume":"34","author":"DE Smith","year":"2013","unstructured":"Smith DE, Cl\u00e9men\u00e7on B, Hediger MA. Proton-coupled oligopeptide transporter family SLC15: physiological, pharmacological and pathological implications. Mol Asp Med. 2013;34(2):323\u201336.","journal-title":"Mol Asp Med"},{"issue":"1","key":"587_CR110","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1124\/jpet.105.089359","volume":"315","author":"SM Ocheltree","year":"2005","unstructured":"Ocheltree SM, Shen H, Hu Y, Keep RF, Smith DE. Role and relevance of peptide transporter 2 (PEPT2) in the kidney and choroid plexus: in vivo studies with glycylsarcosine in wild-type and PEPT2 knockout mice. J Pharmacol Exp Ther. 2005;315(1):240\u20137.","journal-title":"J Pharmacol Exp Ther"},{"issue":"7","key":"587_CR111","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1124\/dmd.107.015263","volume":"35","author":"H Shen","year":"2007","unstructured":"Shen H, Ocheltree SM, Hu Y, Keep RF, Smith DE. Impact of genetic knockout of PEPT2 on cefadroxil pharmacokinetics, renal tubular reabsorption, and brain penetration in mice. Drug Metab Dispos. 2007;35(7):1209\u201316.","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"587_CR112","doi-asserted-by":"publisher","first-page":"R986","DOI":"10.1152\/ajpregu.90744.2008","volume":"296","author":"MA Kamal","year":"2009","unstructured":"Kamal MA, Jiang H, Hu Y, Keep RF, Smith DE. Influence of genetic knockout of Pept2 on the in vivo disposition of endogenous and exogenous carnosine in wild-type and Pept2 null mice. Am J Physiol Integr Comp Physiol. 2009;296(4):R986\u201391.","journal-title":"Am J Physiol Integr Comp Physiol"},{"issue":"4","key":"587_CR113","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1021\/mp049944b","volume":"1","author":"H Shen","year":"2004","unstructured":"Shen H, Smith DE, Keep RF, Brosius FC. Immunolocalization of the proton-coupled oligopeptide transporter PEPT2 in developing rat brain. Mol Pharm. 2004;1(4):248\u201356.","journal-title":"Mol Pharm"},{"issue":"7","key":"587_CR114","doi-asserted-by":"publisher","first-page":"4786","DOI":"10.1074\/jbc.M207397200","volume":"278","author":"H Shen","year":"2003","unstructured":"Shen H, Smith DE, Keep RF, Xiang J, Brosius FC. Targeted disruption of the PEPT2 gene markedly reduces dipeptide uptake in choroid plexus. J Biol Chem. 2003;278(7):4786\u201391.","journal-title":"J Biol Chem"},{"issue":"3","key":"587_CR115","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1124\/jpet.105.090654","volume":"315","author":"H Shen","year":"2005","unstructured":"Shen H, Keep RF, Hu Y, Smith DE. PEPT2 (Slc15a2)-mediated unidirectional transport of cefadroxil from cerebrospinal fluid into choroid plexus. J Pharmacol Exp Ther. 2005;315(3):1101\u20138.","journal-title":"J Pharmacol Exp Ther"},{"key":"587_CR116","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.bcp.2017.02.005","volume":"131","author":"X Chen","year":"2017","unstructured":"Chen X, Keep RF, Liang Y, Zhu H-J, Hammarlund-Udenaes M, Hu Y, et al. Influence of peptide transporter 2 (PEPT2) on the distribution of cefadroxil in mouse brain: a microdialysis study. Biochem Pharmacol. 2017;131:89\u201397.","journal-title":"Biochem Pharmacol"},{"issue":"48","key":"587_CR117","doi-asserted-by":"publisher","first-page":"50042","DOI":"10.1074\/jbc.M407913200","volume":"279","author":"K Engel","year":"2004","unstructured":"Engel K, Zhou M, Wang J. Identification and characterization of a novel monoamine transporter in the human brain. J Biol Chem. 2004;279(48):50042\u20139.","journal-title":"J Biol Chem"},{"issue":"5","key":"587_CR118","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1002\/cpt.442","volume":"100","author":"J Wang","year":"2016","unstructured":"Wang J. The plasma memebrane monoamine transporter (PMAT): structure, function, and role in organic cation disposition. Clin Pharmacol Ther. 2016;100(5):489\u201399.","journal-title":"Clin Pharmacol Ther"},{"issue":"11","key":"587_CR119","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1124\/dmd.115.064824","volume":"43","author":"RS Foti","year":"2015","unstructured":"Foti RS, Swaan PW, Wang J, Duan H, Pan Y, Hu T. Potent and selective inhibition of plasma membrane monoamine transporter by HIV protease inhibitors. Drug Metab Dispos. 2015;43(11):1773\u201380.","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"587_CR120","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1124\/dmd.111.042432","volume":"40","author":"S Itagaki","year":"2012","unstructured":"Itagaki S, Ganapathy V, Ho HTB, Zhou M, Babu E, Wang J. Electrophysiological characterization of the polyspecific organic cation transporter plasma membrane monoamine transporter. Drug Metab Dispos. 2012;40(6):1138\u201343.","journal-title":"Drug Metab Dispos"},{"issue":"3","key":"587_CR121","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1124\/jpet.110.170142","volume":"335","author":"H Duan","year":"2010","unstructured":"Duan H, Wang J. Selective transport of monoamine neurotransmitters by human plasma membrane monoamine transporter and organic cation transporter 3. J Pharmacol Exp Ther. 2010;335(3):743\u201353.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"587_CR122","doi-asserted-by":"publisher","first-page":"F682","DOI":"10.1152\/ajprenal.00302.2006","volume":"292","author":"L Xia","year":"2007","unstructured":"Xia L, Engel K, Zhou M, Wang J. Membrane localization and pH-dependent transport of a newly cloned organic cation transporter (PMAT) in kidney cells. Am J Physiol Physiol. 2007;292(2):F682\u201390.","journal-title":"Am J Physiol Physiol"},{"issue":"45","key":"587_CR123","doi-asserted-by":"publisher","first-page":"41611","DOI":"10.1074\/jbc.M108472200","volume":"276","author":"DH Sweet","year":"2001","unstructured":"Sweet DH, Miller DS, Pritchard JB. Ventricular choline transport: a role for organic cation transporter 2 expressed in choroid plexus. J Biol Chem. 2001;276(45):41611\u20139.","journal-title":"J Biol Chem"},{"issue":"4","key":"587_CR124","doi-asserted-by":"publisher","first-page":"C955","DOI":"10.1152\/ajpcell.1999.276.4.C955","volume":"276","author":"DS Miller","year":"1999","unstructured":"Miller DS, Villalobos AR, Pritchard JB. Organic cation transport in rat choroid plexus cells studied by fluorescence microscopy. Am J Physiol Physiol. 1999;276(4):C955\u201368.","journal-title":"Am J Physiol Physiol"},{"issue":"5088","key":"587_CR125","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1126\/science.1360704","volume":"258","author":"SP Cole","year":"1992","unstructured":"Cole SP, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science (80- ). 1992;258(5088):1650\u20134.","journal-title":"Science (80- )"},{"issue":"1","key":"587_CR126","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1146\/annurev-pharmtox-011613-135959","volume":"54","author":"SPC Cole","year":"2014","unstructured":"Cole SPC. Targeting multidrug resistance protein 1 (MRP1, ABCC1): past, present, and future. Annu Rev Pharmacol Toxicol. 2014;54(1):95\u2013117.","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"587_CR127","doi-asserted-by":"publisher","first-page":"406","DOI":"10.3109\/03602532.2015.1105253","volume":"47","author":"JF Lu","year":"2015","unstructured":"Lu JF, Pokharel D, Bebawy M. MRP1 and its role in anticancer drug resistance. Drug Metab Rev. 2015;47(4):406\u201319.","journal-title":"Drug Metab Rev"},{"issue":"1","key":"587_CR128","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1042\/CBI20110264","volume":"36","author":"AF Semsei","year":"2012","unstructured":"Semsei AF, Erdelyi DJ, Ungvari I, Csagoly E, Hegyi MZ, Kiszel PS, et al. ABCC1 polymorphisms in anthracycline-induced cardiotoxicity in childhood acute lymphoblastic leukaemia. Cell Biol Int. 2012;36(1):79\u201386.","journal-title":"Cell Biol Int"},{"issue":"1","key":"587_CR129","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1002\/cbf.1343","volume":"25","author":"MS Krause","year":"2007","unstructured":"Krause MS, Oliveira LP Jr, Silveira EMS, Vianna DR, Rossato JS, Almeida BS, et al. MRP1\/GS-X pump ATPase expression: is this the explanation for the cytoprotection of the heart against oxidative stress-induced redox imbalance in comparison to skeletal muscle cells? Cell Biochem Funct. 2007;25(1):23\u201332.","journal-title":"Cell Biochem Funct"},{"issue":"24","key":"587_CR130","doi-asserted-by":"publisher","first-page":"3754","DOI":"10.1161\/CIRCULATIONAHA.105.576850","volume":"112","author":"W Leszek","year":"2005","unstructured":"Leszek W, Bettina K, Markus S, Gregor S, Albrecht S, Albert R, et al. NAD(P)H oxidase and multidrug resistance protein genetic polymorphisms are associated with doxorubicin-induced cardiotoxicity. Circulation. 2005;112(24):3754\u201362.","journal-title":"Circulation."},{"issue":"3","key":"587_CR131","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1172\/JCI8267","volume":"105","author":"J Wijnholds","year":"2000","unstructured":"Wijnholds J, de Lange ECM, Scheffer GL, van den Berg D-J, Mol CAAM, van der Valk M, et al. Multidrug resistance protein 1 protects the choroid plexus epithelium and contributes to the blood-cerebrospinal fluid barrier. J Clin Invest. 2000;105(3):279\u201385.","journal-title":"J Clin Invest"},{"issue":"16","key":"587_CR132","first-page":"3537","volume":"57","author":"M Kool","year":"1997","unstructured":"Kool M, De Haas M, Scheffer GL, Scheper RJ, Van Eijk MJT, Juijn JA, et al. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines. Cancer Res. 1997;57(16):3537\u201347.","journal-title":"Cancer Res"},{"issue":"4","key":"587_CR133","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tips.2008.01.006","volume":"29","author":"FGM Russel","year":"2008","unstructured":"Russel FGM, Koenderink JB, Masereeuw R. Multidrug resistance protein 4 (MRP4\/ABCC4): a versatile efflux transporter for drugs and signalling molecules. Trends Pharmacol Sci. 2008;29(4):200\u20137.","journal-title":"Trends Pharmacol Sci"},{"issue":"2","key":"587_CR134","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1016\/j.neuroscience.2004.07.051","volume":"129","author":"AT Nies","year":"2004","unstructured":"Nies AT, Jedlitschky G, K\u00f6nig J, Herold-Mende C, Steiner HH, Schmitt H-P, et al. Expression and immunolocalization of the multidrug resistance proteins, MRP1\u2013MRP6 (ABCC1\u2013ABCC6), in human brain. Neuroscience. 2004;129(2):349\u201360.","journal-title":"Neuroscience."},{"issue":"5","key":"587_CR135","doi-asserted-by":"publisher","first-page":"890","DOI":"10.1002\/cpt.1112","volume":"104","author":"MJ Zamek-Gliszczynski","year":"2018","unstructured":"Zamek-Gliszczynski MJ, Taub ME, Chothe PP, Chu X, Giacomini KM, Kim RB, et al. Transporters in drug development: 2018 ITC recommendations for transporters of emerging clinical importance. Clin Pharmacol Ther. 2018;104(5):890\u20139.","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"587_CR136","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1471-4159.2010.06915.x","volume":"115","author":"V Reichel","year":"2010","unstructured":"Reichel V, Kl\u00e4s J, Fricker G, Masereeuw R. Fluo-cAMP is transported by multidrug resistance-associated protein isoform 4 in rat choroid plexus. J Neurochem. 2010;115(1):200\u20138.","journal-title":"J Neurochem"},{"key":"587_CR137","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.tox.2017.05.019","volume":"386","author":"K Flores","year":"2017","unstructured":"Flores K, Manautou JE, Renfro JL. Gender-specific expression of ATP-binding cassette (Abc) transporters and cytoprotective genes in mouse choroid plexus. Toxicology. 2017;386:84\u201392.","journal-title":"Toxicology."},{"issue":"5","key":"587_CR138","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1021\/mp300518e","volume":"10","author":"N Strazielle","year":"2013","unstructured":"Strazielle N, Ghersi-Egea JF. Physiology of blood\u2013brain interfaces in relation to brain disposition of small compounds and macromolecules. Mol Pharm. 2013;10(5):1473\u201391.","journal-title":"Mol Pharm"},{"issue":"12","key":"587_CR139","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.1016\/j.addr.2004.07.006","volume":"56","author":"N Strazielle","year":"2004","unstructured":"Strazielle N, Khuth ST, Ghersi-Egea J-F. Detoxification systems, passive and specific transport for drugs at the blood\u2013CSF barrier in normal and pathological situations. Adv Drug Deliv Rev. 2004;56(12):1717\u201340.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"587_CR140","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1046\/j.1471-4159.1994.62031089.x","volume":"62","author":"JF Ghersi-Egea","year":"1994","unstructured":"Ghersi-Egea JF, Leninger-Muller B, Suleman G, Siest G, Minn A. Localization of drug-metabolizing enzyme activities to blood-brain interfaces and circumventricular organs. J Neurochem. 1994;62(3):1089\u201396.","journal-title":"J Neurochem"},{"issue":"1","key":"587_CR141","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/2045-8118-10-25","volume":"10","author":"I Kratzer","year":"2013","unstructured":"Kratzer I, Liddelow SA, Saunders NR, Dziegielewska KM, Strazielle N, Ghersi-Egea J-F. Developmental changes in the transcriptome of the rat choroid plexus in relation to neuroprotection. Fluids Barriers CNS. 2013;10(1):25.","journal-title":"Fluids Barriers CNS"},{"issue":"3","key":"587_CR142","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1124\/dmd.31.3.259","volume":"31","author":"L Granberg","year":"2003","unstructured":"Granberg L, \u00d6stergren A, Brandt I, Brittebo EB. CYP1A1 and CYP1B1 in blood-brain interfaces: CYP1A1-dependent bioactivation of 7,12-dimethylbenz(a)anthracene in endothelial cells. Drug Metab Dispos. 2003;31(3):259\u201365.","journal-title":"Drug Metab Dispos."},{"issue":"1","key":"587_CR143","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.bcp.2004.02.036","volume":"68","author":"A Janmohamed","year":"2004","unstructured":"Janmohamed A, Hernandez D, Phillips IR, Shephard EA. Cell-, tissue-, sex- and developmental stage-specific expression of mouse flavin-containing monooxygenases (Fmos). Biochem Pharmacol. 2004;68(1):73\u201383.","journal-title":"Biochem Pharmacol"},{"issue":"3","key":"587_CR144","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1748-1716.1980.tb06525.x","volume":"108","author":"M Lindvall","year":"1980","unstructured":"Lindvall M, Hardebo JE, Owman CH. Barrier mechanisms for neurotransmitter monoamines in the choroid plexus. Acta Physiol Scand. 1980;108(3):215\u201321.","journal-title":"Acta Physiol Scand"},{"issue":"4","key":"587_CR145","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1002\/cne.10093","volume":"442","author":"T Vitalis","year":"2002","unstructured":"Vitalis T, Fouquet C, Alvarez C, Seif I, Price D, Gaspar P, et al. Developmental expression of monoamine oxidases A and B in the central and peripheral nervous systems of the mouse. J Comp Neurol. 2002;442(4):331\u201347.","journal-title":"J Comp Neurol"},{"issue":"4","key":"587_CR146","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1517\/17425255.2.4.559","volume":"2","author":"B Gong","year":"2006","unstructured":"Gong B, Boor PJ. The role of amine oxidases in xenobiotic metabolism. Expert Opin Drug Metab Toxicol. 2006;2(4):559\u201371.","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"9","key":"587_CR147","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1038\/sj.jcbfm.9600267","volume":"26","author":"J-F Ghersi-Egea","year":"2006","unstructured":"Ghersi-Egea J-F, Strazielle N, Murat A, Jouvet A, Bu\u00e9nerd A, Belin M-F. Brain protection at the blood\u2013cerebrospinal fluid interface involves a glutathione-dependent metabolic barrier mechanism. J Cereb Blood Flow Metab. 2006;26(9):1165\u201375.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"14","key":"587_CR148","doi-asserted-by":"publisher","first-page":"3466","DOI":"10.1523\/JNEUROSCI.2967-17.2018","volume":"38","author":"I Kratzer","year":"2018","unstructured":"Kratzer I, Strazielle N, Saudrais E, M\u00f6nkk\u00f6nen K, Malleval C, Blondel S, et al. Glutathione conjugation at the blood\u2013CSF barrier efficiently prevents exposure of the developing brain fluid environment to blood-borne reactive electrophilic substances. J Neurosci. 2018;38(14):3466\u201379.","journal-title":"J Neurosci"},{"issue":"1\u20132","key":"587_CR149","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0304-3940(94)91072-3","volume":"175","author":"B Leininger-Muller","year":"1994","unstructured":"Leininger-Muller B, Ghersi-Egea JF, Siest G, Minn A. Induction and immunological characterization of the uridine diphosphate-glucuronosyltransferase conjugating 1-naphthol in the rat choroid plexus. Neurosci Lett. 1994;175(1\u20132):37\u201340.","journal-title":"Neurosci Lett"},{"issue":"10","key":"587_CR150","first-page":"1039","volume":"26","author":"MK Martinasevic","year":"1998","unstructured":"Martinasevic MK, King CD, Rios GR, Tephly TR. Immunohistochemical localization of UDP-glucuronosyltransferases in rat brain during early development. Drug Metab Dispos. 1998;26(10):1039\u201341.","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"587_CR151","doi-asserted-by":"publisher","first-page":"401","DOI":"10.3109\/03602532.2013.835613","volume":"45","author":"MO James","year":"2013","unstructured":"James MO, Ambadapadi S. Interactions of cytosolic sulfotransferases with xenobiotics. Drug Metab Rev. 2013;45(4):401\u201314.","journal-title":"Drug Metab Rev"},{"issue":"6","key":"587_CR152","first-page":"2734","volume":"86","author":"K Richard","year":"2001","unstructured":"Richard K, Hume R, Kaptein E, Stanley EL, Visser TJ, Coughtrie MW. Sulfation of thyroid hormone and dopamine during human development: ontogeny of phenol sulfotransferases and arylsulfatase in liver, lung, and brain. J Clin Endocrinol Metab. 2001;86(6):2734\u201342.","journal-title":"J Clin Endocrinol Metab"},{"key":"587_CR153","first-page":"83","volume-title":"Microdialysis in CNS PKPD research: unraveling unbound concentrations BT - microdialysis in drug development","author":"M Hammarlund-Udenaes","year":"2013","unstructured":"Hammarlund-Udenaes M. Microdialysis in CNS PKPD research: unraveling unbound concentrations BT - microdialysis in drug development. In: M\u00fcller M, editor. . New York: Springer New York; 2013. p. 83\u2013102."},{"issue":"4","key":"587_CR154","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1124\/dmd.108.022814","volume":"37","author":"J Watson","year":"2009","unstructured":"Watson J, Wright S, Lucas A, Clarke KL, Viggers J, Cheetham S, et al. Receptor occupancy and brain free fraction. Drug Metab Dispos. 2009;37(4):753\u201360.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"587_CR155","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2174\/138920008783331077","volume":"9","author":"JH Lin","year":"2008","unstructured":"Lin JH. CSF as a surrogate for assessing CNS exposure: an industrial perspective. Curr Drug Metab. 2008;9(1):46\u201359.","journal-title":"Curr Drug Metab"},{"issue":"3","key":"587_CR156","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1111\/j.1742-7843.2009.00517.x","volume":"106","author":"M Hammarlund-Udenaes","year":"2010","unstructured":"Hammarlund-Udenaes M. Active-site concentrations of chemicals \u2013 are they a better predictor of effect than plasma\/organ\/tissue concentrations? Basic Clin Pharmacol Toxicol. 2010;106(3):215\u201320.","journal-title":"Basic Clin Pharmacol Toxicol"},{"issue":"9","key":"587_CR157","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1124\/dmd.105.008201","volume":"34","author":"X Liu","year":"2006","unstructured":"Liu X, Smith BJ, Chen C, Callegari E, Becker SL, Chen X, et al. Evaluation of cerebrospinal fluid concentration and plasma free concentration as a surrogate measurement for brain free concentration. Drug Metab Dispos. 2006;34(9):1443\u20137.","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"587_CR158","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1124\/dmd.120.000099","volume":"48","author":"Y Nagaya","year":"2020","unstructured":"Nagaya Y, Katayama K, Kusuhara H, Nozaki Y. Impact of P-glycoprotein\u2013mediated active efflux on drug distribution into lumbar cerebrospinal fluid in nonhuman primates. Drug Metab Dispos. 2020;48(11):1183\u201390.","journal-title":"Drug Metab Dispos"},{"key":"587_CR159","first-page":"acs.molpharmace","volume":"4","author":"Y Yaguchi","year":"2019","unstructured":"Yaguchi Y, Tachikawa M, Zhang Z, Terasaki T. Organic anion-transporting polypeptide 1a4 (Oatp1a4\/Slco1a4) at the blood\u2013arachnoid barrier is the major pathway of sulforhodamine-101 clearance from cerebrospinal fluid of rats. Mol Pharm. 2019;4:acs.molpharmaceut.9b00005.","journal-title":"Mol Pharm"},{"issue":"4","key":"587_CR160","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1152\/physrev.00027.2007","volume":"88","author":"E Sykov\u00e1","year":"2008","unstructured":"Sykov\u00e1 E, Nicholson C. Diffusion in Brain Extracellular Space. Physiol Rev. 2008;88(4):1277\u2013340.","journal-title":"Physiol Rev"},{"issue":"3","key":"587_CR161","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1113\/JP275105","volume":"596","author":"ME Pizzo","year":"2018","unstructured":"Pizzo ME, Wolak DJ, Kumar NN, Brunette E, Brunnquell CL, Hannocks M-J, et al. Intrathecal antibody distribution in the rat brain: surface diffusion, perivascular transport and osmotic enhancement of delivery. J Physiol. 2018;596(3):445\u201375.","journal-title":"J Physiol"},{"issue":"4","key":"587_CR162","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1007\/s10928-019-09641-8","volume":"46","author":"H-Y Chang","year":"2019","unstructured":"Chang H-Y, Wu S, Meno-Tetang G, Shah DK. A translational platform PBPK model for antibody disposition in the brain. J Pharmacokinet Pharmacodyn. 2019;46(4):319\u201338.","journal-title":"J Pharmacokinet Pharmacodyn"}],"container-title":["The AAPS Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-021-00587-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1208\/s12248-021-00587-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1208\/s12248-021-00587-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T08:04:52Z","timestamp":1675238692000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1208\/s12248-021-00587-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,3]]},"references-count":162,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,5]]}},"alternative-id":["587"],"URL":"https:\/\/doi.org\/10.1208\/s12248-021-00587-9","relation":{},"ISSN":["1550-7416"],"issn-type":[{"value":"1550-7416","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,3]]},"assertion":[{"value":"5 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclaimer"}}],"article-number":"61"}}